Mahesh Vasantha Madhavan

Mahesh Madhavan practices at Trustees of Columbia University in the City of New York in New York, New York.

Mahesh Madhavan's NPI, 1104244102, was assigned on April 7, 2014. Mahesh Madhavan graduated from Columbia University Vagelos College of Physicians and Surgeons in 2014. Mahesh Madhavan holds New York license 288950.

Mahesh Madhavan's primary practice is Trustees of Columbia University in the City of New York, at 630 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 342-5155.

Mahesh Madhavan's primary practice is Trustees of Columbia University in the City of New York in New York, New York. Mahesh Madhavan is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Mahesh Madhavan to 4 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mahesh Madhavan practices, 8 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Mahesh Madhavan's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Mahesh Madhavan is board certified in cardiovascular disease by the American Board of Internal Medicine. Mahesh Madhavan is licensed in New York.

CMS data shows 1,002 Medicare services from Mahesh Madhavan across 16 procedure codes in 2024, for 342 Medicare patients. Medicare paid $123,705 for them.

CMS counts 342 Medicare patients who saw Mahesh Madhavan in 2024. The largest group is 75 to 84, with 135 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mahesh Madhavan's median patient age at 75, with 45% women.

In 2024, Mahesh Madhavan wrote 642 Medicare Part D claims for 103 patients. 78% of them were for generic drugs. CMS names the drug for 536 of them, across 17 drugs with 11 or more claims each, at $151,837 in total drug cost. In 2023, CMS named 72 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Mahesh Madhavan for performance year 2024, reported through an alternative payment model (APM). Mahesh Madhavan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Mahesh Madhavan as offering telehealth. CMS counts 26 procedures of coronary angioplasty and stenting by Mahesh Madhavan, more than 60% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 47 papers to Mahesh Madhavan, published from 2020 to 2025. 2022 was the busiest year, with 9. The most frequent topics are COVID-19, Coronary Artery Disease and Percutaneous Coronary Intervention. Mahesh Madhavan has published most often in J Soc Cardiovasc Angiogr Interv. Mahesh Madhavan's most frequent co-authors are Martin Bert Leon, MD, Ajay J. Kirtane, MD and Aakriti Gupta, BS, MD.

CMS Open Payments shows 220 general payments to Mahesh Madhavan from 28 drug and device companies from 2020 to 2025. Grants make up the largest share, 49% of the total. Boston Scientific Corporation paid the most, $16,549.

Mahesh Madhavan graduated from Columbia University Vagelos College of Physicians and Surgeons in 2014.